Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Infect Control Hosp Epidemiol. 2022 Nov;43(11):1647-1655. doi: 10.1017/ice.2021.487. Epub 2021 Dec 2.
To describe the cumulative seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies during the coronavirus disease 2019 (COVID-19) pandemic among employees of a large pediatric healthcare system.
DESIGN, SETTING, AND PARTICIPANTS: Prospective observational cohort study open to adult employees at the Children's Hospital of Philadelphia, conducted April 20-December 17, 2020.
Employees were recruited starting with high-risk exposure groups, utilizing e-mails, flyers, and announcements at virtual town hall meetings. At baseline, 1 month, 2 months, and 6 months, participants reported occupational and community exposures and gave a blood sample for SARS-CoV-2 antibody measurement by enzyme-linked immunosorbent assays (ELISAs). A post hoc Cox proportional hazards regression model was performed to identify factors associated with increased risk for seropositivity.
In total, 1,740 employees were enrolled. At 6 months, the cumulative seroprevalence was 5.3%, which was below estimated community point seroprevalence. Seroprevalence was 5.8% among employees who provided direct care and was 3.4% among employees who did not perform direct patient care. Most participants who were seropositive at baseline remained positive at follow-up assessments. In a post hoc analysis, direct patient care (hazard ratio [HR], 1.95; 95% confidence interval [CI], 1.03-3.68), Black race (HR, 2.70; 95% CI, 1.24-5.87), and exposure to a confirmed case in a nonhealthcare setting (HR, 4.32; 95% CI, 2.71-6.88) were associated with statistically significant increased risk for seropositivity.
Employee SARS-CoV-2 seroprevalence rates remained below the point-prevalence rates of the surrounding community. Provision of direct patient care, Black race, and exposure to a confirmed case in a nonhealthcare setting conferred increased risk. These data can inform occupational protection measures to maximize protection of employees within the workplace during future COVID-19 waves or other epidemics.
描述在 2019 年冠状病毒病(COVID-19)大流行期间,一家大型儿科医疗机构员工中严重急性呼吸冠状病毒 2 型(SARS-CoV-2)抗体的累积血清阳性率。
设计、地点和参与者:这是一项针对费城儿童医院成年员工的前瞻性观察队列研究,于 2020 年 4 月 20 日至 12 月 17 日进行。
从高风险暴露人群开始,利用电子邮件、传单和虚拟市政厅会议上的公告招募员工。在基线、1 个月、2 个月和 6 个月时,参与者报告职业和社区暴露情况,并通过酶联免疫吸附测定(ELISA)进行 SARS-CoV-2 抗体检测。进行了事后 Cox 比例风险回归模型分析,以确定与血清阳性率增加相关的因素。
共有 1740 名员工入组。6 个月时,累积血清阳性率为 5.3%,低于估计的社区点血清阳性率。直接护理员工的血清阳性率为 5.8%,非直接患者护理员工的血清阳性率为 3.4%。大多数基线时血清阳性的参与者在随访评估中仍为阳性。在事后分析中,直接患者护理(风险比 [HR],1.95;95%置信区间 [CI],1.03-3.68)、黑种人(HR,2.70;95% CI,1.24-5.87)和非医疗环境中确诊病例的暴露(HR,4.32;95% CI,2.71-6.88)与血清阳性风险显著增加相关。
员工 SARS-CoV-2 血清阳性率仍低于周围社区的时点阳性率。提供直接患者护理、黑种人以及在非医疗环境中接触确诊病例会增加感染风险。这些数据可以为未来 COVID-19 浪潮或其他流行病期间在工作场所内最大限度地保护员工提供职业保护措施。